<?xml version="1.0" encoding="UTF-8"?>
<p>A vaccine is urgently desired to prevent COVID-19 and thus stall the complications and deaths occurring from community transmission of the infection (
 <xref rid="B12" ref-type="bibr">12</xref>). Several COVID-19 vaccines are under clinical trials (
 <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/novel-coronavirus-landscape-covid-19cf1952c105464714aaaf8c7cd5c5cc8b.pdf?sfvrsn=d6073093_5&amp;download=true" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/docs/default-source/coronaviruse/novel-coronavirus-landscape-covid-19cf1952c105464714aaaf8c7cd5c5cc8b.pdf?sfvrsn=d6073093_5&amp;download=true</ext-link>). It is very important to ensure the immunogenicity, and safety of any vaccine before it is licensed. The most recent vaccine candidate produced by Oxford University called ChAdOx1 nCoV-19 is now in the last phase of clinical trials and has shown optimistic results (
 <xref rid="B13" ref-type="bibr">13</xref>).
</p>
